Category: Insights

The technology behind predictive models and analytics has advanced dramatically over the past decade. It may be tempting for pharma companies to begin analytics instead of following an effective predictive analytics strategy. Associate Partner Emily Eller describes steps for pharma marketers to reach and engage their customers more effectively in PM360 magazine.

An effective, fair and motivating incentive compensation plan is key to a happy sales force and a successful product launch. Emerging pharma companies should tailor their incentive compensation plans to each product launch, implement a measurement strategy, and incorporate new data and technology into their plans.

An emerging biopharma company faces unique challenges at launch and, therefore, must work hard to build a comprehensive launch roadmap that is grounded in data, incorporates the right technology tools, and accounts for the inherent uncertainty associated with launching a first product. Erik Cruz writes in Pharmaceutical Executive about how commercial leaders of emerging companies can maximize results at launch.

There are three big commonly held misperceptions that can hamper a pharmaceutical company’s product launch. Instead of relying too heavily on instinct and experience, pharmaceutical companies should use advanced data analytics techniques to overcome these misperceptions, improve forecasts and increase sales. Read Steve Trokenheim’s article in PM360 to learn more.